» Articles » PMID: 8142192

Ten Year Mortality in Relation to Original Size of Myocardial Infarct: Results from the Gothenburg Metoprolol Study

Overview
Journal Br Heart J
Date 1994 Mar 1
PMID 8142192
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To describe the relation between the extent of a myocardial infarct, measured according to maximum serum enzyme activity of lactate dehydrogenase, and mortality at 10 years.

Patients: In 759 patients with acute myocardial infarction in whom serum activity of heat stable lactate dehydrogenase had been determined every 12 hours for 108 hours after randomisation in an early intervention trial with metoprolol.

Main Outcome Measure: Mortality at 10 years in relation to quartile of maximum serum lactate dehydrogenase activity and history of cardiovascular disease.

Results: Among all patients mortality at 10 years was 39% in the lowest quartile, 51% in the second quartile, 50% in the third, and 59% in the fourth (p < 0.001 for relation between infarct size and 10 year mortality). Among patients without a history of myocardial infarction, angina pectoris, diabetes mellitus, or hypertension the mortality in each quartile was 29%, 32%, 41%, and 56%, respectively (p < 0.001 for relation between infarct size and 10 year mortality). Among patients with any of these risk indicators the association between the estimated infarct size and mortality at 10 years was weak (p < 0.05).

Conclusion: Estimated size of a myocardial infarct and mortality over 10 years seem to be related but mainly in patients without a history of cardiovascular disease.

Citing Articles

Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α.

Siraj M, Mundil D, Beca S, Momen A, Shikatani E, Afroze T J Clin Invest. 2020; 130(3):1392-1404.

PMID: 31985487 PMC: 7269572. DOI: 10.1172/JCI99934.


Early kinetics of serum Interleukine-17A and infarct size in patients with reperfused acute ST-elevated myocardial infarction.

Bochaton T, Mewton N, Thiam N, Lavocat F, Baetz D, Dufay N PLoS One. 2017; 12(11):e0188202.

PMID: 29166391 PMC: 5699816. DOI: 10.1371/journal.pone.0188202.


Pharmacokinetics and safety of a single dose of the novel necrosis inhibitor LC28-0126 in healthy male subjects.

Kim S, Chung H, Lee S, Cho S, Cho H, Kim S Br J Clin Pharmacol. 2016; 83(6):1205-1215.

PMID: 28002882 PMC: 5427235. DOI: 10.1111/bcp.13213.


Use of carvedilol in hypertension: an update.

Leonetti G, Egan C Vasc Health Risk Manag. 2012; 8:307-22.

PMID: 22661898 PMC: 3363143. DOI: 10.2147/VHRM.S31578.

References
1.
Peter T, Norris R, Clarke E, Heng M, Singh B, Williams B . Reduction of enzyme levels by propranolol after acute myocardial infarction. Circulation. 1978; 57(6):1091-5. DOI: 10.1161/01.cir.57.6.1091. View

2.
Roe C . Validity of estimating myocardial infarct size from serial measurements of enzyme activity in the serum. Clin Chem. 1977; 23(10):1807-12. View

3.
Taylor G, HUMPHRIES J, Mellits E, Pitt B, Schulze R, Griffith L . Predictors of clinical course, coronary anatomy and left ventricular function after recovery from acute myocardial infarction. Circulation. 1980; 62(5):960-70. DOI: 10.1161/01.cir.62.5.960. View

4.
Grande P, Hansen B, Christiansen C, Naestoft J . Acute myocardial infarct size estimated by serum CK-MB determinations: clinical accuracy and prognostic relevance utilizing a practical modification of the isoenzyme approach. Am Heart J. 1981; 101(5):582-6. DOI: 10.1016/0002-8703(81)90224-6. View

5.
Hjalmarson A, Elmfeldt D, Herlitz J, Holmberg S, Malek I, Nyberg G . Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet. 1981; 2(8251):823-7. DOI: 10.1016/s0140-6736(81)91101-6. View